I mentioned a while back, as in August 20, 2018 – 23andMe to Offer Paid Upgrades for Earlier Chipset in the Near Future, that 23andMe was going to offer an upgrade price for those of us who had previously tested on earlier chips. I tested on the v3 chip back in 2013. They stopped offering me new health reports about the time I posted the above information. I believe they will charge the same $125 upgrade price if you tested with the v4 chip. Don’t know if you tested with the v1 or v2 chips. E-mail time stamp was about an hour and half before I scheduled this post.
It took 23andMe a fairly long time to make the announcement. I don’t have the money to do the upgrade right now, but I would probably wait until the $199 test was on sale for $149 to order it as I don’t see $125 as a great deal. That’s what they normally charge if you now buy the $99 test and want to upgrade to the $199 test at a later date. In my case, I tested back when they only charged $99 and included health reports as part of the deal.
The reason for me going with the $149 sale price is that means they have to send me a new kit which will cut into their profit margin a lot more than if they simply re-run my v3 chip sample using the remaining DNA in that kit.
As an early adopter of 23andMe, you were
genotyped on a previous version of our chip and
don’t have access to all our newly released reports
and features. You can now upgrade to the most
recent version of our chip – V5 – to receive the latest
Health + Ancestry Service experience.
Buy a Chip Upgrade for $125 and receive:
The latest Health Service reports*
Type 2 Diabetes (Powered by 23andMe
Research), Familial Hypercholesterolemia
The latest Ancestry enhancements
Get refinements to Ancestry Composition,
including newly added populations and
Ancestry Detail Reports.
A better sharing experience
Easily compare your reports with friends and
family members who were recently
The 23andMe kit that you receive as part of the Chip Upgrade purchase must only be used by the person for whom the kit was intended. 23andMe reserves the right to invalidate a kit without providing a refund if 23andMe determines that the submitted sample belongs to someone other than the person for whom the kit was intended for the chip upgrade. New results will be applied to your existing 23andMe profile. In rare cases, your results may change. If you have a 23andMe Reports Archive, certain new report results may be different from the results in your Reports Archive.
*The 23andMe PGS test health predisposition reports include both reports that meet US FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. For important information and limitations regarding each genetic health risk report, visit 23andme.com/test-info/
You are receiving this email because you are a customer of 23andMe.